Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Sep 18 - Sep 23
Prevalence of use and interest in using glucagonlike peptide1 receptor agonists for weight loss: a population study in Great Britain
This analytical capability increases confidence in structural verification during pharmaceutical manufacturing
Using prescription registries to define continuous drug use: how to fill gaps between prescriptions
The disparity in coverage between the anti-diabetic and anti-obesity GLP-1s shows how payer behavior is driven by the perceived medical necessity of products by their intended use, not by the molecule itself
Speciln lekce veden zkuenmi lektory
US$ 27.37
US$ 26.83
US$ 24.44
US$ 23.66
US$ 24.93
